Dr. Lars-Gerrit Lüßmann, LL.M. (New York University)

Lars-Gerrit specialises in capital markets transactions with a focus on subscription of shares and flotations as well as public take-overs and M&A transactions. He is head of the Corporate/ Capital Markets practice group at Taylor Wessing Germany.

A further area of expertise is providing legal and strategic advice to executive boards and supervisory boards of listed companies. His clients include German and international financial institutes, listed companies and investors.

Show full CV Hide full CV

Career

Since 2011	Partner, Taylor Wessing
2002 – 2010	Associate, Linklaters LLP, Frankfurt
2004 – 2005	Client secondment to J.P. Morgan AG, Frankfurt

1996 – 1999

Legal clerkship, Landshut, Munich and Lausanne

More Less

Education

2003	Doctoral degree on corporate governance, capital markets and fair value accounting, University of Konstanz
2002	Admitted as a lawyer, Frankfurt am Main
2000	Masters, Law in Comparative Jurisprudence, New York University School of Law

1999	Second state examination, Munich
1996	First state examination, Munich
1991 – 1996	Legal studies, Universities of Freiburg i. Brsg., Lausanne and Munich

More Less

Publications

Firmenchefs unterschätzen Aktivisten, Kommentar in: Handelsblatt, Nr. 247, 12/2020

Neue Phänomene in der Hauptversammlung, in: Börsenzeitung Nr. 104, 06/2019

Obstruktive Großaktionäre - Der Feind in meinem Haus, Legal Tribute Online, 05/2019

Einmal ist keinmal? Neues zum Acting in Concert, in: Going Public Special Kapitalmarktrecht, 03/2019

Wie weit reicht der Arm des Aufsichtsrats?, in: Legal Tribune Online, 11/2018

Additional languages

English

Expertise

Sectors Life sciences & healthcare Financial institutions & insurance Automotive & mobility Real estate Medical devices Pharmaceuticals

Experience

Formycon

Under the leadership of the Frankfurt-based Taylor-Wessing partners Lars-Gerrit Lüßmann and Michael Sinhart, Formycon AG and ATHOS KG are merging their development activities in the field of so-called biosimilars, the follow-up products of biological medicines (biologics), in a long-term strategic partnership. The centrepiece of this agreement is Formycon AG’s participation in the rights of two biosimilars. The volume of the legally complex transaction (aggregate counter-performance) adds up to approximately 650 million euros.

Hauck & Aufhäuser

A Taylor Wessing team led by Frankfurt-based partners Lars-Gerrit Lüßmann and Ulrich Reers advised Hauck & Aufhäuser Investment Banking and Polish universal bank mBank in their role as exchange trustee and settlement agent on the voluntary public takeover/exchange offer by Frankfurt-listed Vita 34 AG, Leipzig, to the shareholders of Warsaw-listed stem cell bank Polski Bank Komórek Macierzystych S.A, Warsaw (PBKM). The transaction is the first cross-border exchange offer for a Polish listed company to date.

Awards

JUVE Handbook 2021/ 2022	"thinks along extremely flexibly", client
JUVE Handbook 2021/2022	Frequently recommended lawyer for corporate law
JUVE Handbook 2020/2021	„intelligent, thoughtful, precise and hard-working“, client
IFLR 1000 2020	Notable practitioner: Capital markets (Germany)
JUVE Handbook 2019/2020	Frequently recommended: Corporate Law
Legal 500 Germany 2019	"recognised in advising management boards and supervisory boards"
Legal 500 Europe, Middle East and Africa 2019	Recommended lawyer - Germany: "fast, competent and masters complexity", "recognised in advising management boards and supervisory boards"
Legal 500 Europe, Middle East and Africa 2017	Recommended lawyer - Germany:“… the ‘outstanding’ Lars-Gerrit Lüßmann [is] recommended“